Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GEV | PH |
|---|---|---|
| Price | $953.50 | $972.58 |
| Change today | ▲ 0.18% | ▲ 0.14% |
| Market cap | $253.95B | $122.65B |
| Return, 3 months | -9.8% | +1.4% |
| Return, year to date | +46.2% | +11.3% |
| Return, 1 year | +51.9% | +31.0% |
| P/E (TTM) | 27.3 | 34.1 |
| P/B | 21.2 | 8.0 |
| P/E percentile vs own 5y | 13th | 79th |
| Dividend yield | 0.21% | 0.76% |
| Revenue growth (YoY, latest qtr) | +21.9% | +9.8% |
| Net profit growth (YoY) | +31.9% | +18.3% |
| Gross margin | 20.2% | 37.7% |
| Operating margin | 4.4% | 21.6% |
| Net margin | 23.0% | 17.0% |
| Return on equity | 91.5% | 25.1% |
| Analyst target vs. price | +31.1% | +24.1% |
| Analyst buy share | 89% | 77% |
| RSI (14) | 49 | 53 |
| 30-day volatility | 47.5% | 22.6% |
| Max drawdown, 1 year | -25.5% | -19.3% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.